0001628280-25-051119
SEC filingRevenue grew 21.6% YoY to $123.3M, driven by volume and mix, with gross margin expanding to 37.6%.
For the three months ended September 30, 2025, Microvast reported revenue of $123.3 million, a 21.6% increase year-over-year from $101.4 million. This growth was primarily driven by a 15.6% increase in sales volume to 501.7 MWh. Gross profit rose 38.1% to $46.4 million, with gross margin expanding to 37.6% from 33.2% in the prior year period. Management attributed the margin improvement to higher production utilization, which enhanced fixed cost absorption, and a favorable product mix with a growing share of higher-margin battery solutions.
Operating expenses increased 21.6% to $33.5 million. General and administrative expenses rose 66.1% to $19.7 million, driven by $3.7 million in unfavorable exchange rate fluctuations and $5.6 million in litigation expense, partially offset by lower share-based compensation. Research and development expenses decreased 27.5% to $7.8 million, primarily due to lower share-based compensation and reduced personnel costs. Selling and marketing expenses increased 21.0% to $6.0 million, reflecting higher service fees for business development.
Profit from operations improved to $13.0 million from $7.2 million, an 80.8% increase. However, net loss was $1.5 million compared to net income of $13.2 million in the prior year, primarily due to a $12.6 million loss from changes in fair value of warrant and convertible loan, compared to a $2.8 million gain in the prior year.
Revenue by geography showed significant mix shift. Europe remained the largest region, contributing 64% of total revenue ($77.9 million), up from 59% in the prior year. This growth was driven by a surge in France revenue to $33.2 million from $0.6 million, while Italy revenue declined to $29.1 million from $54.7 million. Asia & Pacific revenue was relatively flat at $38.8 million, with China revenue slightly decreasing to $27.5 million. U.S. revenue grew to $6.6 million from $2.6 million, reflecting early progress in the domestic market.
Customer concentration remained notable, with two customers each accounting for 24% of Q3 2025 revenue. The company's order backlog stood at $237.7 million, equivalent to approximately 1,045.5 MWh, with the majority expected to be fulfilled in 2025 and 2026.
Management expressed confidence in the company's trajectory, noting that positive operating profit and operating cash flow during the nine months ended September 30, 2025 alleviated substantial doubt about its ability to continue as a going concern. The company's liquidity position includes $142.6 million in cash and cash equivalents and restricted cash as of September 30, 2025.
Key strategic priorities include completing the Huzhou Phase 3.2 production line (2 GWh capacity) by year-end 2025, with pilot production of 55Ah cells expected by end of 2025. The Clarksville, Tennessee facility remains paused pending additional financing, with a strategic pivot from NMC to 565Ah LFP battery production for the U.S. ESS market. The company also highlighted its all-solid-state battery breakthrough, with plans to establish a pilot line for production study.
Management expects continued positive operating cash flow, supported by the $237.7 million order backlog and stable gross margins. The company secured a $70.1 million bank loan during the nine months ended September 30, 2025, and entered into a Controlled Equity Offering in October 2025, receiving $12.6 million in net proceeds to date.
As of September 30, 2025, Microvast held $90.7M in cash and equivalents, plus $51.9M in restricted cash, totaling $142.6M. Total debt stood at $353.9M, comprising $118.8M in bank borrowings (short-term $84.4M, long-term $34.4M), $41.7M in bonds payable, and $193.5M in a convertible loan measured at fair value. The convertible loan fair value increased from $104.6M at year-end 2024 due to a $91.0M fair value loss recognized in the nine months. Shareholders' equity was $358.1M, down from $387.9M at December 31, 2024, driven by a net loss of $45.8M and other comprehensive income of $13.7M. The company's going concern disclosure highlights substantial doubt, mitigated by positive operating cash flow ($59.5M in nine months), refinancing history, and a new equity offering facility.
Microvast reported $44.1M in purchase commitments primarily for inventory and $10.1M in capital commitments for property, plant and equipment. Additionally, product warranty liabilities totaled $38.8M ($10.3M current, $28.4M non-current). The company faces several legal contingencies, including arbitration exposure of approximately $36M from a Clenera supply agreement dispute (final award pending), and other litigation with uncertain outcomes.
No share buybacks or dividends were disclosed. Debt cash flows showed $70.1M in new bank borrowings and $66.0M in repayments, plus $1.4M bond repayments, resulting in net cash inflow from debt of $2.7M. Capital expenditures were $19.2M (5.8% of sales), primarily for manufacturing capacity. The company also has a $125M at-the-market equity offering program, with $12.6M raised subsequent to quarter end.
Microvast operates as a single segment: developing and selling lithium-ion batteries for commercial EVs and energy storage. Geographic revenue for the nine months: China $106.4M, Other Asia Pacific $30.1M, Italy $81.8M, France $60.9M, other Europe $34.1M, and U.S. $17.8M. Europe contributed 53% of total revenue.
Operating cash flow (CFO) of $59.5M for the nine months ended September 30, 2025 represents a significant turnaround from -$3.3M in the prior-year period, despite a net loss of $45.8M. The primary driver was a $91.0M non-cash change in fair value of warrant liability and convertible loan, which added to cash flow from operations. Working capital changes also contributed positively, with inventories decreasing by $17.4M and accrued expenses increasing by $20.3M, partially offset by a $38.2M decline in advance from customers and a $23.0M increase in accounts receivable.
Capital expenditures (capex) of $19.2M were lower than the prior period's $27.4M, reflecting reduced investing intensity. Free cash flow (not explicitly stated) would be approximately $40.3M (CFO minus capex), but the company does not report this metric. Financing activities used $9.5M, driven by net debt repayments and deferred capex payments, compared to $46.6M generated in the prior period.
Anomalies include the large non-cash warrant liability adjustment and a $38.2M decline in advance from customers, which may indicate changes in customer prepayment terms. Overall, cash generation improved markedly, but reliance on non-cash adjustments and working capital swings warrants monitoring.